GN Store Nord (GN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Margin expansion and record free cash flow achieved in Q3 2024, driven by transformation synergies and cost control, despite uneven divisional growth.
Hearing division delivered double-digit organic growth and market share gains, while Enterprise faced revenue pressure in Central Europe and Gaming & Consumer was impacted by product wind-downs.
Group EBITA rose 29% year-over-year to DKK 553 million, with margin up 3.6pp to 13.3%.
DKK 115 million in synergies realized in Q3, with over DKK 300 million year-to-date; on track for DKK 400 million in 2024 and DKK 600 million by 2026.
Divestment of Dansk HøreCenter finalized; wind-down of Elite and Talk product lines on track for completion by year-end.
Financial highlights
Q3 2024 revenue was DKK 4,164 million, down 6% year-over-year; organic revenue declined 4% (flat excluding wind-down products).
Gross margin improved to 54.8% from 50.1% in Q3 2023.
EBITA margin rose to 13.3% (up 3.6pp year-over-year); adjusted EBITA margin 13.8%.
Free cash flow excl. M&A reached DKK 786 million, the highest Q3 in company history.
Adjusted leverage reduced to 3.5x from 4.9x year-over-year.
Outlook and guidance
2024 organic revenue growth guidance: 1–2% for the group, or 3–4% excluding consumer wind-down.
Hearing division expected to trend toward upper half of 8–12% organic growth; Enterprise at -3%; Gaming & Consumer: -10% to -2%.
EBITA margin guidance confirmed at 12–13%, with underlying margin about 1pp higher excluding wind-down costs.
Free cash flow excl. M&A upgraded to above DKK 1,100 million.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025 - Q3 2025 saw 1% organic growth, 11% EBITA margin, and strong cash flow, led by Hearing.GN
Q3 202513 Nov 2025